Our impact
Mini tumour organoids to help personalise cancer treatment
You helped fund research that allowed scientists to grow mini tumour organoids in the lab from a patient’s own cancer cells to study the disease and personalise treatment.
Helping to develop new blood cancer drugs
Your support helped Professor Mark Cragg discover how drugs could be used to target and destroy cancer cells and helped develop new blood cancer treatments.
Clinical trials to stop bowel cancer coming back
Your support in 2005 has helped launch clinical trials testing a promising new treatment option for people with bowel cancer.
Making the most of your donations to start new cures
How do we know that what we are doing works? We explore the average return on investment of our research funding.
Developing a new type of cancer immunotherapy
With your support Dr John Maher's impact on cancer research has led to the development of a brand new type of immunotherapy that is now in clinical trials.
Using lithium to prevent bowel cancer
Your support helped Professor Louis Vermeulen make a discovery that has led to the psychiatric drug lithium being tested in clinical trials to prevent bowel cancer.